Marksans Pharma Limited (BOM:524404)
India flag India · Delayed Price · Currency is INR
249.95
-2.00 (-0.79%)
At close: May 28, 2025

Marksans Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Cash & Equivalents
7,0424,0333,8242,0642,122
Upgrade
Short-Term Investments
7.422,7103,3281,399-
Upgrade
Trading Asset Securities
-269.945.44.352.61
Upgrade
Cash & Short-Term Investments
7,0507,0137,1583,4672,124
Upgrade
Cash Growth
0.52%-2.03%106.47%63.19%126.66%
Upgrade
Accounts Receivable
5,4004,5324,1683,9482,719
Upgrade
Other Receivables
122.6106.6248.543.71.02
Upgrade
Receivables
5,5234,6384,2173,9912,721
Upgrade
Inventory
8,4556,1794,8474,2444,043
Upgrade
Prepaid Expenses
-251.26198.04159.83-
Upgrade
Other Current Assets
1,014543.05332.57149.34140.04
Upgrade
Total Current Assets
22,04118,62516,75312,0129,028
Upgrade
Property, Plant & Equipment
8,9546,8113,8693,4232,540
Upgrade
Long-Term Investments
-1.68---
Upgrade
Goodwill
409.28394.99384.89300.25195.86
Upgrade
Other Intangible Assets
727.32647.62707.97585.69474.36
Upgrade
Long-Term Deferred Tax Assets
---38.577.99
Upgrade
Other Long-Term Assets
264.42329.41189.1341.6241.58
Upgrade
Total Assets
32,39626,81021,90416,40112,288
Upgrade
Accounts Payable
3,0572,6832,3062,0011,687
Upgrade
Accrued Expenses
14.47442.56220.96131.01103.53
Upgrade
Short-Term Debt
230.85290.91415.88362.92187.4
Upgrade
Current Portion of Long-Term Debt
---50-
Upgrade
Current Portion of Leases
354.92249.51156.68280.5260.37
Upgrade
Current Income Taxes Payable
299.41199.08252.78173.27300.21
Upgrade
Other Current Liabilities
816.7533.6657.59563.67651.52
Upgrade
Total Current Liabilities
4,7733,8983,4103,5622,990
Upgrade
Long-Term Debt
----50
Upgrade
Long-Term Leases
2,6331,900656.89414.3493.26
Upgrade
Long-Term Deferred Tax Liabilities
36.62106.2153.86176.2180.63
Upgrade
Other Long-Term Liabilities
-6.639.32.836.94
Upgrade
Total Liabilities
7,5035,9504,2534,1713,235
Upgrade
Common Stock
453.16453.16453.16409.31409.31
Upgrade
Additional Paid-In Capital
-5,0455,0451,7321,751
Upgrade
Retained Earnings
-13,82710,9138,2306,487
Upgrade
Comprehensive Income & Other
24,2161,3261,0401,651217.68
Upgrade
Total Common Equity
24,66920,65117,45212,0238,865
Upgrade
Minority Interest
224.7208.52199.1207.01188.57
Upgrade
Shareholders' Equity
24,89420,85917,65112,2309,054
Upgrade
Total Liabilities & Equity
32,39626,81021,90416,40112,288
Upgrade
Total Debt
3,2192,4411,2291,108391.03
Upgrade
Net Cash (Debt)
3,8304,5725,9292,3591,733
Upgrade
Net Cash Growth
-16.22%-22.88%151.30%36.10%193.41%
Upgrade
Net Cash Per Share
8.4510.0914.275.764.23
Upgrade
Filing Date Shares Outstanding
452.73453.16453.16409.31409.31
Upgrade
Total Common Shares Outstanding
452.73453.16453.16409.31409.31
Upgrade
Working Capital
17,26814,72613,3438,4506,039
Upgrade
Book Value Per Share
54.4945.5738.5129.3721.66
Upgrade
Tangible Book Value
23,53319,60816,35911,1378,195
Upgrade
Tangible Book Value Per Share
51.9843.2736.1027.2120.02
Upgrade
Land
-5.185.14.674.14
Upgrade
Buildings
-2,2871,6331,5111,318
Upgrade
Machinery
-4,4453,3553,0382,515
Upgrade
Construction In Progress
-53.8172.466.9556
Upgrade
Leasehold Improvements
-105.64---
Upgrade
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.